Codex DNA
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Codex DNA's past years’ income statements indicate that its last revenue has increased compared to the previous period by 148% to $27,435,000. Profit margin reached -177%. Total operating expenses were $62,080,000.

Profit Margin

Codex DNA, Inc. (NASDAQ:DNAY): Profit margin
2020 6.57M -18.01M -273.87%
2021 11.04M -38.95M -352.78%
2022 27.43M -48.42M -176.5%

DNAY Income Statement (2020 – 2022)

2022 2021 2020
Revenue
Revenue
27.43M11.04M6.57M
Cost of revenue
11.84M6.74M2.95M
Gross profit
15.59M4.29M3.62M
Operating exp.
Research and development
23.46M14.54M8.92M
Selling and marketing
16.48M10.89M6.93M
Total operating expenses
62.08M39.67M19.98M
Operating income
-49.71M-40.31M-16.36M
Other income (expenses), net
1.26M1.36M-1.64M
Income before tax
-48.44M-38.94M-18.00M
Income tax expense
-24K14K5K
Net income
-48.42M-38.95M-18.01M
Earnings per share
Basic EPS
-1.64-1.83-0.84
Diluted EPS
-1.64-1.83-0.84
Data sourceData source